Form 4 for CRVO CervoMed Inc.
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001437749-21-025138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-03 | 2021-11-01 | CRVO | Cobuzzi Robert Joseph Jr. | Pres, CEO, Dir | M - OptEx | — | +16.4K | 30.4K | +117% | — |
| D | 2021-11-03 | 2021-11-01 | CRVO | Cobuzzi Robert Joseph Jr. | Pres, CEO, Dir | M - OptEx | $0.00 | -16.4K | 81.8K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-01 | M | A | 16,350 | — | 30,350 | D | — | — | (F1) On November 1, 2021, the Reporting Person received 16,350 shares in connection with the vesting of previously awarded restricted stock units, each unit representing a contingent right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continuing service with the Issuer, the remaining restricted stock units will vest in equal, tri-monthly installments. |
| 2 | Derivative | Restricted Stock Units | 2021-11-01 | M | D | 16,350 | $0.00 | 81,750 | D | — · — to — | 16,350 Common Stock | (F1) On November 1, 2021, the Reporting Person received 16,350 shares in connection with the vesting of previously awarded restricted stock units, each unit representing a contingent right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continuing service with the Issuer, the remaining restricted stock units will vest in equal, tri-monthly installments. |